entertainment -WSS

entertainment

author：knowledge 2025-09-27 22:48:24 - browse：57

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Some medical students still think black patients feel less pain

Wikipedia

WSS

FDA needs staff influx to meet gene therapy needs, Marks says

Medical students need to learn the potent medicine of empathy

AI models in health care face new federal disclosure requirements

Patients' immediate access to test results puts radiologists in a bind

Chemotherapy shortages won’t get better under Biden’s latest plan

Pregnancy discrimination could be enabled by AI

focus

entertainment

Wikipedia

Medicare details structure of new drug price negotiation program

CMS should re

Alkermes shareholders re

CMS should re

Duchenne breakthrough therapy leaves behind pioneering families

Teach medical students about patients with intellectual disabilities

ChatGPT in medicine: STAT answers readers' burning questions

Spinal cord stimulation reduces pain in amputees, study finds

Peter Hotez and the public health issue of online harassment

U.S. death rates show how politics are affecting public health

Wikipedia

STAT letters to the editor on burnt

Congress: Prevent baby formula shortages by passing a new bill

Protect nursing home residents from future pandemics

What PEPFAR has meant on the ground in Ukraine

Lawsuit challenges CMS nursing home minimum staffing rule

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

hotspot

hotspot

Wikipedia

knowledge